Clinical Trial Update: Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous T cells with or without cyclophosphamide and fludarabine for recurrent or persistent advanced ovarian epithelial cancer, pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Autologous T Cells
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED | Results posted: 2023-09-15